Literature DB >> 1385056

Determination of tumor marker levels in cystic fluid of benign liver cysts.

K Iwase1, H Takenaka, S Oshima, A Yagura, Y Nishimura, K Yoshidome, T Tanaka.   

Abstract

The levels of tumor markers in cystic fluid and serum were measured in six patients with benign biliary cyst of the liver. AFP in the cystic fluid was lower than the upper normal limit for serum in all cases, and CEA in the cystic fluid was higher than the upper normal limit for serum in one of the six cases. CA19-9, DU-PAN 2, and SPAN 1 in cystic fluid were much higher than the upper normal limit for serum in all cases (more than 100-fold for CA19-9, twofold for DU-PAN 2, and ninefold for SPAN 1). CA19-9, DU-PAN 2, and SPAN 1 in cystic fluid were significantly higher than the levels in the corresponding serum. Positive immunohistochemical staining against CA19-9, DU-PAN 2, and SPAN 1 was observed in the cytoplasm of the epithelial cells of the cyst wall. These results suggested that the high concentrations of CA19-9, DU-PAN 2, and SPAN 1 in the cystic fluid were due to secretion from the epithelial cells in the benign biliary cysts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385056     DOI: 10.1007/bf01299853

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.

Authors:  R Farini; C Fabris; P Bonvicini; A Piccoli; G del Favero; R Venturini; A Panucci; R Naccarato
Journal:  Eur J Cancer Clin Oncol       Date:  1985-04

2.  [A new series of monoclonal antibodies against pancreatic cancer cells].

Authors:  Y S Chung; K Satake; K Umeyama; Y S Kim
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-01

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody.

Authors:  D M Mahvi; W C Meyers; R C Bast; H F Seigler; R S Metzgar
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

5.  Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.

Authors:  M J Borowitz; F L Tuck; W F Sindelar; P D Fernsten; R S Metzgar
Journal:  J Natl Cancer Inst       Date:  1984-05       Impact factor: 13.506

6.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

7.  The detection of human pancreatic cancer-associated antigen in the serum of cancer patients.

Authors:  Y S Chung; J J Ho; Y S Kim; H Tanaka; B Nakata; A Hiura; H Motoyoshi; K Satake; K Umeyama
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

8.  Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.

Authors:  N Sawabu; D Toya; Y Takemori; N Hattori; M Fukui
Journal:  Int J Cancer       Date:  1986-05-15       Impact factor: 7.396

Review 9.  Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation.

Authors:  A M Neville; D J Laurence
Journal:  Int J Cancer       Date:  1974-07-15       Impact factor: 7.396

10.  Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

Authors:  R S Metzgar; M T Gaillard; S J Levine; F L Tuck; E H Bossen; M J Borowitz
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

View more
  7 in total

Review 1.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  Laparoscopic deroofing for symptomatic liver cysts: report of a case.

Authors:  K Iwase; T Takao; H Watanabe; Y Tanaka; T Kido; N Ogawa; S Sunada; K Santoh; E Hamada; N Ono
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 3.  Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management.

Authors:  Zhi Ven Fong; Andrea M Wolf; Cataldo Doria; Adam C Berger; Ernest L Rosato; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2012-06-12       Impact factor: 3.452

4.  Hemorrhage into a simple liver cyst: diagnostic implications of a recent case.

Authors:  K Hanazaki; M Wakabayashi; H Mori; H Sodeyama; K Yoshizawa; S Yokoyama; Y Sode; N Kawamura; T Miyazaki
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

Review 5.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

6.  Hemorrhagic hepatic cysts mimicking biliary cystadenoma.

Authors:  You-Lei Zhang; Lei Yuan; Feng Shen; Yi Wang
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

7.  Treatment of symptomatic hepatic cysts by percutaneous instillation of minocycline hydrochloride.

Authors:  N Yamada; H Shinzawa; K Ukai; N Makino; T Matsuhashi; H Wakabayashi; H Togashi; T Takahashi
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.